# Julia Dan

> Julia Dan is a startup investor at Oxford Bioscience Partners. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Oxford Bioscience Partners](https://shizune.co/investors/profile/oxford-bioscience-partners)
- Last updated: Aug 2026

Julia Dan is a startup investor at Oxford Bioscience Partners. Julia Dan joined Oxford Bioscience Partners as a Venture Partner in 2013, bringing extensive experience of bridging the US and China markets in the healthcare industry. Most recently, Julia co-founded BGI Americas Corporation and brought BGI, a Chinese genomics sequencing service provider, into the US market. As Chief Executive Officer of BGIAmericas, Julia built a full staff and achieved positive returns within the first year of operations, and collaborated with leading pharmaceutical companies, including Merck, Pfizer, Novartis and Eli Lilly, etc..Prior to BGI Americas, Julia co-launched Sanofi-Genzyme’s operations in China, including managing a cross-functional team of eleven business units and functional groups, and supported the company’s acquisitions and licensing activities in the US and China. Before Genzyme, Julia had seven years of operational and management experience at China Construction Bank, the second largest bank in the world, including co-launching its operations in Germany.Julia holds a BA from Beijing Foreign Studies University China, an MBA from the Tuck School of Business at Dartmouth College, and an MPH from Harvard University School of Public Health.

## About Oxford Bioscience Partners

VC Fund · Boston, United States

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stagesituations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.

5 contacts available at Oxford Bioscience Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Alan G. Walton | Senior General Partner | https://shizune.co/investors/profile/alan-g-walton |
| Alan Watson | Executive-in-Residence | https://shizune.co/investors/profile/alan-watson-2 |
| Julia Dan | Venture Partner | https://shizune.co/investors/profile/julia-dan |
| Manuel A. Navia | Executive-in-Residence | https://shizune.co/investors/profile/manuel-a-navia |
| Paul Tu | Venture Partner | https://shizune.co/investors/profile/paul-tu |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co